Skip to search.
 TSX Up 0.84% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS

11.75 Down 0.24(2.00%) May 17, 4:00PM EDT|After Hours : 11.75 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Prev Close:11.99
Open:12.03
Bid:9.36 x 100
Ask:12.60 x 100
1y Target Est:15.00
Beta:0.36
Next Earnings Date:29-Jul-13NBIX Earnings announcement
Day's Range:11.68 - 12.10
52wk Range:6.25 - 12.85
Volume:862,897
Avg Vol (3m):520,627
Market Cap:784.10M
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NBIXDown 2.00%784.10M
PFZ.L 0.00%173.71B
GSK.LUp 0.29%82.95B
AZN.LDown 0.45%42.18B
JNJ.MXUp 0.01%3.00T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.78
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-13) :-0.79
Quarterly EPS Est (Jun-13) :-0.20
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback